DETERMINATION OF RANGE, QUANTIFICATION LIMIT, AND DETECTION LIMIT IN SARS-COV-2 PSEUDOLENTIVIRUS-BASED NEUTRALIZATIONÂ ASSAY
The efficacy testing of the COVID-19 vaccine can be conducted using a virus neutralization assay. This test requires BSL-3 handling facilities because the wild-type SARS-CoV-2 virus is highly infectious and dangerous. Through pseudotyping, the formed virus cannot replicate, allowing neutralization...
Saved in:
Main Author: | Karima Bestari, Putri |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/87773 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
DEVELOPMENT OF PSEUDOLENTIVIRUS NEUTRALIZATION ASSAY WITH SPIKE VARIANTS OF SARS-COV-2
by: Firdaus Syuaib, Afina -
SPECIFICITY DETERMINATION OF A PSEUDOLENTIVIRUS-BASED NEUTRALIZATION ASSAY
by: Aissa Gunawan, Hefina -
Limited sensitivity of a rapid SARS-CoV-2 antigen detection assay for surveillance of asymptomatic individuals in Thailand
by: Anek Mungomklang, et al.
Published: (2022) -
Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays
by: Tham, JWM, et al.
Published: (2021) -
Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA
by: Maturada Patchsung, et al.
Published: (2020)